GPT and metabolic dysfunction-associated steatohepatitis: When we divided patients into two categories according to NASH stages (Stages 0–I and II–III), we found that compared to patients with Stage 0–I NASH, those with Stage II–III NASH had greater baseline values for ALT (29 ± 8 vs. 67 ± 25, p = 0.001) and AST (25 ± 13 vs. 47 ± 23, p = 0.046).